Company Filing History:
Years Active: 2009-2013
Title: The Innovations of Andreas Gschwind
Introduction
Andreas Gschwind is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the modulation of receptor tyrosine kinases. With a total of 2 patents, Gschwind's work has implications for understanding and treating various diseases.
Latest Patents
Gschwind's latest patents focus on the inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation. The inventions relate to the modulation of transactivation of receptor tyrosine kinases by G protein or G protein-coupled receptor (GPCR) mediated signal transduction. This involves inhibiting the activity of the metalloprotease TACE/ADAM17 and/or the activity of the receptor tyrosine kinase ligand amphiregulin.
Career Highlights
Andreas Gschwind is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., where he conducts his research. His work has been instrumental in advancing our understanding of cellular signaling pathways.
Collaborations
Gschwind has collaborated with prominent scientists in his field, including Axel Ullrich and Stefan Hart. These collaborations have further enriched his research and contributed to the development of innovative solutions in biotechnology.
Conclusion
Andreas Gschwind's contributions to the field of biotechnology through his patents and research collaborations highlight his role as a leading inventor. His work continues to influence advancements in medical science and therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.